Bioventus BVS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $132.09M-16.3% | $157.9M+13.9% | $138.65M-6.1% | $147.66M+19.2% | $123.88M-19.4% | ||
| $41.32M-15.9% | $49.12M+10.6% | $44.42M-2.5% | $45.57M+11.6% | $40.82M-19.9% | ||
| $90.77M-16.6% | $108.78M+15.4% | $94.23M-7.7% | $102.09M+22.9% | $83.06M-19.1% | ||
| 68.7%-0.2pp | 68.9%+0.9pp | 68%-1.2pp | 69.1%+2.1pp | 67%+0.2pp | ||
| $2.47M-18.0% | $3.01M+2.9% | $2.92M-7.8% | $3.17M+5.3% | $3.01M-7.9% | ||
| $78.33M-5.4% | $82.76M+5.2% | $78.66M-0.6% | $79.11M+7.6% | $73.5M-15.4% | ||
| $8.42M-56.8% | $19.49M+73.2% | $11.25M-38.7% | $18.37M+277% | $4.87M— | ||
| 6.4%-6.0pp | 12.3%+4.2pp | 8.1%-4.3pp | 12.4%+8.5pp | 3.9%— | ||
| -$4.33M+18.5% | -$5.31M+14.1% | -$6.18M+17.6% | -$7.49M+0.2% | -$7.51M+16.5% | ||
| -$3.9M+27.0% | -$5.34M+18.8% | -$6.58M+18.3% | -$8.06M+2.8% | -$8.29M-6.8% | ||
| $4.52M-68.1% | $14.14M+203% | $4.67M-54.7% | $10.31M+402% | -$3.42M-6,347% | ||
| $571K+118% | -$3.18M-578% | $664K-36.2% | $1.04M+1,196% | -$95K— | ||
| $3.11M-78.9% | $14.76M+368% | $3.16M-57.7% | $7.46M+383% | -$2.64M-580% | ||
| 2.4%-7.0pp | 9.3%+7.1pp | 2.3%-2.8pp | 5.1%+7.2pp | -2.1%-1.9pp | ||
| $0.04-81.0% | $0.21+320% | $0.05-54.5% | $0.11+375% | -$0.04— | ||
| $19.62M-37.1% | $31.18M+37.6% | $22.66M-25.5% | $30.42M+81.8% | $16.73M+399% | ||
| 14.9%-4.9pp | 19.7%+3.4pp | 16.3%-4.3pp | 20.6%+7.1pp | 13.5%+11.3pp | ||
| $8.42M-56.8% | $19.49M+73.2% | $11.25M-38.7% | $18.37M+277% | $4.87M+154% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bioventus's revenue?
- Bioventus (BVS) generated $576.3M in revenue over the trailing twelve months, up 1.5% year over year.
- Is Bioventus profitable?
- Bioventus reported $28.5M in net income over the trailing twelve months, a 4.9% net margin.
- What are Bioventus's profit margins?
- Gross margin is 68.7% and operating margin is 10.0%, with a 4.9% net margin.
- What is Bioventus's earnings per share?
- Bioventus's diluted EPS over the trailing twelve months is $0.41.
- Where does Bioventus's income statement data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
